NCT00840671 - Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke | Biotech Hunter

Enrollment

119

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

July 31, 2008

Conditions

Stroke

Interventions

DRUG

Cerebrolysin

Cerebrolysin, 30 ml/day as intravenous infusion, first infusion after completion of thrombolytic therapy. Daily infusion for 10 consecutive days.

DRUG

0.9% Saline Solution

0.9% Saline Solution, 30 ml/day as intravenous infusion, first infusion after completion of thrombolytic therapy. Daily infusion for 10 consecutive days.

Trial Locations (15)

1020

Krankenhaus der Barmherzigen Brüder/Abteilung für Neurologie, Vienna

1525

Clinical Hospital Centre Ljubljana, Ljubljana

3400

Außenstelle Landesklinikum Donauregion Gugging, Gugging

4021

AKH Linz, Abteilung Neurologie & Psychiatrie, Linz

6020

Universitätsklinik Innsbruck, Dept. of Neurology, Innsbruck

9020

LKH Klagenfurt, Abteilung für Neurologie, Klagenfurt

10000

Medical School of Zagreb, Zagreb

University Hospital Sorrores Misericoridae, Zagreb

21000

Clinical Hospital Split, Dept. of Neurology, Split

30460

University Hospital Plzen, Pilsen

51000

Klinicka Bolnicki Centar, Klinika za Nevrologiju, Rijeka

65691

St. Ann's Hospital, Dept. of Neurology, Brno

70384

Blessed Mary Anthony Hospital, Dept. of Neurology, Ostrava Vitkovice

70852

Clinic of Neurology, Faculty Hospital Ostrava, Ostrava

81369

University Hospital, Comenius University, Dept. of Neurology, Bratislava